Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

NCT03793478 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Quizartinib
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Intrathecal (IT) triple chemotherapy prophylaxis
DRUG: Etoposide

Sponsor

Daiichi Sankyo

Collaborators

[object Object]
[object Object]